Cancer Biotechnology

Cancer is that the degeneration of one kind of cell within an organism into something anarchistically powerful, and nasty. As this new cell-form uncontrollably proliferates and embeds itself during a tissue host, a tumor is born. Once tumor cells later spread, the prognosis for its victim rapidly diminishes, a process known as metastasis. Detected at an early stage, cancer is benign and solvable. However once metastases appear the challenge becomes a full new (depressingly difficult) ball-game. Research targeted on understanding the molecular mechanisms of cancer, and developing diagnostics and drugs for its cure. The foremost cross-disciplinary of contemporary research areas, cancer biotechnology research involves scientists from medicine, biology, physics and engineering disciplines.

 

    Related Conference of Cancer Biotechnology

    February 23-24, 2023

    27th Annual Meeting on Pharmaceutical Biotechnology

    Amsterdam, Netherlands
    April 06-07, 2023

    26th World Congress on Advanced Biotechnology

    Barcelona, Spain
    June 28-29, 2023

    27th Global Congress on Biotechnology

    Paris, France
    July 10-11, 2023

    3rd World Congress on Food Science and Biotechnology

    Prague, Czech Republic
    September 25-26, 2023

    6th Annual Congress on Biosimilars

    Taipei, Taiwan
    October 23-24, 2023

    3rd International Conference on Bioprinting

    Los Angeles, USA
    October 23-24, 2023

    8th International summit on Biomanufacturing

    Los Angeles, USA
    October 23-24, 2023

    27th European Biotechnology Congress

    Rome, Italy
    November 21-22, 2023

    27th Biotechnology Congress: Research & Innovations

    Berlin, Germany

    Cancer Biotechnology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in